Is Otrexup Approved for Rheumatoid Arthritis?
No, Otrexup (methotrexate injection) is not FDA-approved for rheumatoid arthritis (RA). It carries approvals for severe psoriasis and adult and pediatric polyarticular idiopathic juvenile RA, but not standard adult RA.[1]
What Conditions Is Otrexup Approved For?
Otrexup is indicated for:
- Active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years and older.
- Severe active psoriasis in adults who respond inadequately to other treatments.
Methotrexate, the active ingredient, is a disease-modifying antirheumatic drug (DMARD) commonly prescribed off-label for RA due to its efficacy in clinical practice, but Otrexup's labeling excludes adult RA.[1][2]
Why Not for Adult RA Specifically?
Otrexup's single-dose auto-injector format targets weekly self-administration for psoriasis and pJIA, where dosing aligns. Adult RA often requires more flexible titration, leading to approvals for other methotrexate forms (oral or multi-dose injections) instead. No patent or exclusivity blocks RA approval; it's a formulation distinction.[1]
How Does Otrexup Compare to RA Methotrexate Options?
| Feature | Otrexup | Standard Methotrexate (e.g., Rasuvo, generic) |
|---------|---------|---------------------------------------------|
| RA Approval | No (pJIA yes) | Yes, for adult RA |
| Dosing | Fixed weekly doses (7.5-25 mg) via auto-injector | Flexible (often 7.5-25 mg weekly, multi-dose) |
| Ease of Use | Self-injection, no reconstitution | Varies; some auto-injectors approved for RA |
| Cost | Higher (~$500-800/month without insurance) | Lower for generics (~$20-100/month) |
Patients with RA typically use Rasuvo (similar auto-injector, RA-approved) or oral methotrexate.[3]
Can Doctors Prescribe Otrexup Off-Label for RA?
Yes, physicians may prescribe it off-label for adult RA based on methotrexate's established role as first-line therapy, supported by ACR guidelines. Evidence from trials shows similar efficacy and safety across formulations, but insurance may not cover it for unapproved uses.[2][4]
Common RA Patient Concerns with Methotrexate Injections
- Side Effects: Nausea (most frequent), fatigue, liver enzyme elevation; mitigated by folic acid.
- Monitoring: Monthly blood tests initially for liver/kidney function.
- Switching Forms: Easy transition from oral to Otrexup if GI issues arise, even if off-label.[4]
[1]: Otrexup Prescribing Information (FDA)
[2]: ACR RA Guidelines 2021
[3]: Drugs.com - Methotrexate Comparisons
[4]: Arthritis Foundation - Methotrexate Overview